Taken together, these results suggest the existence of a specific lncRNA profile for luminal BC cell lines; specifically, GATA3-AS1, DSCAM-AS1, and particularly luminal B-specific lncRNAs, such as VIPR1-AS1, could be related to the clinical features associated with the development of luminal breast cancer. This evidence concerns the gene GATA3 and breast cancer.